Diabetic Peripheral Neuropathic Pain (DPNP)

PHASE2CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diabetic Peripheral Neuropathic Pain
Interventions
DRUG

BMS-954561

DRUG

Pregabalin

DRUG

Placebo matching BMS-954561

DRUG

Placebo matching Pregabalin

Trial Locations (24)

14618

Finger Lakes Clinical Research, Rochester

21079

Local Institution, Dijon

27103

Pmg Research Of Winston-Salem, Winston-Salem

27834

Physicians East P.A., Greenville

32806

Compass Research, Llc, Orlando

33445

Brain Matters Research, Delray Beach

33716

Comprehensive Clinical Development, Inc., St. Petersburg

34471

Renstar Medical Research, Ocala

35216

Achieve Clinical Research, Llc, Birmingham

37203

Clinical Research Associates, Inc., Nashville

42431

Commonwealth Biomedical Research, Llc, Madisonville

43623

Neurology & Neuroscience Center Of Ohio, Toledo

44093

Local Institution, Nantes

44311

Radiant Research, Inc., Akron

60010

Northwest Neurology Ltd., Lake Barrington

63141

Mercy Health Research, St Louis

64114

The Center For Pharmaceutical Research. Pc, Kansas City

75230

Dallas Diabetes & Endocrine Center, Dallas

77566

R/D Clinical Research, Inc., Lake Jackson

85023

Arizona Research Center, Phoenix

90717

Torrance Clinical Research, Lomita

94598

Diablo Clinical Research, Inc., Walnut Creek

95032

Office Of Richard S. Cherlin, Md, Los Gatos

06003

Local Institution, Nice

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY